ZNF322A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.422200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.613000E-01
Normal-vs-Stage2
6.482400E-01
Normal-vs-Stage3
1.353160E-01
Normal-vs-Stage4
4.904000E-01
Stage1-vs-Stage2
7.850100E-02
Stage1-vs-Stage3
3.341700E-02
Stage1-vs-Stage4
9.089400E-01
Stage2-vs-Stage3
1.755010E-01
Stage2-vs-Stage4
1.861430E-01
Stage3-vs-Stage4
4.227600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.336200E-01
Normal-vs-AfricanAmerican
7.187400E-01
Normal-vs-Asian
3.632000E-01
Caucasian-vs-AfricanAmerican
3.385800E-01
Caucasian-vs-Asian
3.453800E-01
AfricanAmerican-vs-Asian
1.162010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.976400E-01
Normal-vs-Female
6.775800E-01
Male-vs-Female
6.133200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.531400E-01
Normal-vs-Age(41-60Yrs)
8.077200E-01
Normal-vs-Age(61-80Yrs)
5.541000E-01
Normal-vs-Age(81-100Yrs)
7.302400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.599200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.176800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.901800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.362800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.420600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.242600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.941600E-01
Normal-vs-Daily Drinker
1.478610E-01
Normal-vs-Weekly Drinker
9.618800E-01
Normal-vs-Occasional Drinker
8.987000E-01
Normal-vs-Social Drinker
9.147400E-01
Non Drinker-vs-Daily Drinker
2.611400E-01
Non Drinker-vs-Weekly Drinker
1.895430E-01
Non Drinker-vs-Occasional Drinker
2.848000E-01
Non Drinker-vs-Social Drinker
1.418580E-01
Daily Drinker-vs-Weekly Drinker
9.396300E-03
Daily Drinker-vs-Occasional Drinker
3.670100E-02
Daily Drinker-vs-Social Drinker
1.291550E-02
Weekly Drinker-vs-Occasional Drinker
8.483200E-01
Weekly Drinker-vs-Social Drinker
7.865800E-01
Occasional Drinker-vs-Social Drinker
6.835400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.057220E-01
Normal-vs-Grade 2
9.249600E-02
Normal-vs-Grade 3
8.085800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.627400E-01
Grade 1-vs-Grade 3
7.296000E-01
Grade 1-vs-Grade 4
1.057220E-01
Grade 2-vs-Grade 3
8.109200E-01
Grade 2-vs-Grade 4
9.249600E-02
Grade 3-vs-Grade 4
8.085800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.592000E-01
Normal-vs-NonDiabetic
7.416200E-01
Diabetic-vs-NonDiabetic
3.065400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.294200E-01
Normal-vs-NoPancreatitis
7.367800E-01
Pancreatitis-vs-NoPancreatitis
2.620600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.633400E-01
Normal-vs-N1
6.931400E-01
N0-vs-N1
4.047800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.945200E-01
Normal-vs-TP53-NonMutant
9.483200E-01
TP53-Mutant-vs-TP53-NonMutant
2.967400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
